These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22535390)

  • 1. Fibroblast growth factor receptor 4 Gly388Arg polymorphism associated with severity of gallstone disease in a Chinese population.
    Chen Q; Li WJ; Wan YY; Yu CD; Li WG
    Genet Mol Res; 2012 Mar; 11(1):548-55. PubMed ID: 22535390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor 4 Gly388Arg polymorphism in Chinese gastric cancer patients.
    Shen YY; Lu YC; Shen DP; Liu YJ; Su XY; Zhu GS; Yin XL; Ni XZ
    World J Gastroenterol; 2013 Jul; 19(28):4568-75. PubMed ID: 23901234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor receptor 4 polymorphisms and coronary artery disease: a case control study.
    Zhu Q; Liu T
    Mol Biol Rep; 2012 Sep; 39(9):8679-85. PubMed ID: 22696188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between fibroblast growth factor receptor 4 Gly388Arg polymorphism and ischaemic stroke.
    Zhang HF; Zhao KJ; Yang PF; Fang YB; Zhang YH; Liu JM; Huang QH
    J Int Med Res; 2012; 40(5):1708-14. PubMed ID: 23206452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-Specific Association Between FGFR4 Gly388Arg Gene Variants and Hypertension.
    Al-Daghri NM; Mohammed AK; Al-Attas OS; Draz HM; Alokail MS
    Genet Test Mol Biomarkers; 2017 Jul; 21(7):422-427. PubMed ID: 28650667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Mol Genet Metab; 2008 May; 94(1):83-9. PubMed ID: 18178499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 4 polymorphisms and the prognosis of non-Hodgkin lymphoma.
    Cha Z; Zang Y; Guo H; Gu H; Tu X; Song H; Qian B
    Mol Biol Rep; 2014 Feb; 41(2):1165-70. PubMed ID: 24381107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol 7alpha-hydrolase (CYP7A1) c.-278A>C promoter polymorphism in gallstone disease patients.
    Juzyszyn Z; Kurzawski M; Lener A; Modrzejewski A; Pawlik A; Droździk M
    Genet Test; 2008 Mar; 12(1):97-100. PubMed ID: 18307386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
    Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
    Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 4 polymorphism is associated with increased risk and poor prognosis of non-Hodgkin's lymphoma.
    Gao L; Feng Z; Li Q; Li L; Chen L; Xiao T
    Tumour Biol; 2014 Apr; 35(4):2997-3002. PubMed ID: 24248544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
    Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
    Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.
    Xu B; Tong N; Chen SQ; Hua LX; Wang ZJ; Zhang ZD; Chen M
    BMC Cancer; 2011 Feb; 11():84. PubMed ID: 21349172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP7A1 (-204 A>C; rs3808607 and -469 T>C; rs3824260) promoter polymorphisms and risk of gallbladder cancer in North Indian population.
    Srivastava A; Choudhuri G; Mittal B
    Metabolism; 2010 Jun; 59(6):767-73. PubMed ID: 20005541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population.
    Ma Z; Tsuchiya N; Yuasa T; Inoue T; Kumazawa T; Narita S; Horikawa Y; Tsuruta H; Obara T; Saito M; Satoh S; Ogawa O; Habuchi T
    Int J Cancer; 2008 Dec; 123(11):2574-9. PubMed ID: 18756523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATP binding cassette G8 T400K polymorphism may affect the risk of gallstone disease among Chinese males.
    Wang Y; Jiang ZY; Fei J; Xin L; Cai Q; Jiang ZH; Zhu ZG; Han TQ; Zhang SD
    Clin Chim Acta; 2007 Sep; 384(1-2):80-5. PubMed ID: 17612515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease.
    Ma L; Zhang H; Han C; Tong D; Zhang M; Yao Y; Luo Y; Liu X
    DNA Cell Biol; 2012 Jun; 31(6):1064-9. PubMed ID: 22313031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
    Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
    Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.
    Ho CK; Anwar S; Nanda J; Habib FK
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):94-6. PubMed ID: 19918264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
    Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
    Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition.
    Ye Y; Li J; Jiang D; Li J; Xiao C; Li Y; Han C; Zhao C
    Cancer Res Treat; 2020 Oct; 52(4):1162-1177. PubMed ID: 32599983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.